← BOSTON SCIENTIFIC CORP BSX
Market Price
$51.83
Market Cap
$76.86B
P/E Ratio
26.72
Revenue (FY 2025)
↑19.9% YoY
$20.07B
3-Yr CAGR: 16.5%
Net Income
↑56.4% YoY
$2.90B
Net Margin: 14.4%
Free Cash Flow
↑38.3% YoY
$3.66B
FCF Yield: 4.76%
EPS (Diluted)
↑55.2% YoY
$1.94
Basic: $1.96
Return on Equity
Efficiency
12.0%
ROA: 6.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BSX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $8,386.0M | — | $5,962.0M | $347.0M | — | $0.25 | — | $972.0M | $596.0M | — |
| FY 2017 | $9,048.0M | +7.9% | $6,455.0M | $104.0M | -70.0% | $0.08 | -68.0% | $1,426.0M | $1,107.0M | +85.7% |
| FY 2018 | $9,823.0M | +8.6% | $7,010.0M | $1,671.0M | +1,506.7% | $1.19 | +1,387.5% | $310.0M | $-6.0M | -100.5% |
| FY 2019 | $10,735.0M | +9.3% | $7,619.0M | $4,700.0M | +181.3% | $3.33 | +179.8% | $1,836.0M | $1,375.0M | +23,016.7% |
| FY 2020 | $9,913.0M | -7.7% | $6,448.0M | $-115.0M | -102.4% | $-0.08 | -102.4% | $1,508.0M | $1,132.0M | -17.7% |
| FY 2021 | $11,888.0M | +19.9% | $8,177.0M | $985.0M | +956.5% | $0.69 | +962.5% | $1,870.0M | $1,316.0M | +16.3% |
| FY 2022 | $12,682.0M | +6.7% | $8,726.0M | $642.0M | -34.8% | $0.45 | -34.8% | $1,526.0M | $938.0M | -28.7% |
| FY 2023 | $14,240.0M | +12.3% | $9,895.0M | $1,570.0M | +144.5% | $1.07 | +137.8% | $2,503.0M | $1,792.0M | +91.0% |
| FY 2024 | $16,747.0M | +17.6% | $11,490.0M | $1,853.0M | +18.0% | $1.25 | +16.8% | $3,435.0M | $2,645.0M | +47.6% |
| FY 2025 | $20,074.0M | +19.9% | $13,853.0M | $2,898.0M | +56.4% | $1.94 | +55.2% | $4,534.0M | $3,658.0M | +38.3% |
Valuation
Market Price
$51.83
Market Cap
$76.86B
Enterprise Value
$86.33B
P/E Ratio
26.72
P/B Ratio
3.18
FCF Yield
4.76%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
69.01%
Operating Margin
18.00%
Net Margin
14.44%
Return on Equity (ROE)
11.96%
Return on Assets (ROA)
6.64%
Asset Turnover
0.46x
Revenue 3-Yr CAGR
16.54%
Financial Health & Liquidity
Current Ratio
0.21
Cash Ratio
0.61
Debt / Equity
0.472
Debt / Assets
0.262
Cash & Equivalents
$1.97B
Total Debt
$11.44B
Book Value / Share
$16.30
Cash Flow Efficiency
Operating Cash Flow
$4.53B
Capital Expenditures (CapEx)
$876.00M
Free Cash Flow
$3.66B
OCF / Revenue
22.59%
FCF / Revenue
18.22%
FCF 3-Yr CAGR
57.40%
Per Share Metrics
EPS (Diluted)
$1.94
EPS (Basic)
$1.96
Dividends / Share
N/A
Book Value / Share
$16.30
EPS YoY Growth
55.20%
Balance Sheet (FY 2025)
Total Assets
$43.67B
Total Liabilities
$43.67B
Stockholders' Equity
$24.23B
Current Assets
$660.00M
Current Liabilities
$3.20B